Moleculin Biotech Inc (MBRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.02M
Last updated: Nov 17, 2026 at 10:59 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 27.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 38.6, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about MBRX
News
MBRX Valuation
MBRX Profitability: Margins, ROIC and FCF
Moleculin Biotech (MBRX) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -1372.0%
Moleculin Biotech Competitors
The companies most similar to Moleculin Biotech (MBRX) include Marker Therapeutics, GT Biopharma and Tempest Therapeutics.
Sector: Healthcare
Companies most similar to Moleculin BiotechMBRX Analyst Ratings
Moleculin Biotech (MBRX) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- 0
MBRX Earnings: Beat Rate and Next Report
Moleculin Biotech (MBRX) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is expected on Mar 16, 2027.
- Beat rate
- 5 of 8 quarters (62.5%)
- Average surprise
- 13.0%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$8.70
MBRX Earnings Date
MBRX reports Mar 16, 2027. The date is estimated.
MBRX Earnings Call
The latest MBRX earnings call transcript on file is labeled 2025Q1.
Read the 2025Q1 transcriptMBRX ETF Holders
GNG tracks 1 ETF that holds MBRX.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About MBRX
When does MBRX report earnings?
Moleculin Biotech Inc (MBRX) is expected to report earnings on Mar 16, 2027.
Does MBRX pay dividends?
Moleculin Biotech Inc (MBRX) does not currently pay a regular dividend.
What is MBRX's market cap?
Moleculin Biotech Inc (MBRX) has a market capitalization of $8.02M with a current stock price of $7.14.
MBRX pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.